Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/BNTX

BNTX

BioNTech SE

Healthcare - DE - listed in USD

BioNTech SE (BNTX) is a biotechnology company focused on developing and commercializing immunotherapies for cancer and infectious diseases. The company offers a broad portfolio of products and services, including mRNA-based therapeutics and…

HQ: Mainz, RP, Germanywww.biontech.de

USD96.73+0.34%vs prev. close

Market snapshot

Price

USD96.73

Daily move

+0.34%

P/E

—

EPS TTM

-7.83

Dividend yield

—

Beta

1.29

Market cap

24.3B

Price history

BNTX price

USD

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
BioNTech	BNTX	Biotechnology	24.3	—	—	-6.8%	+4.3%	+6.8%	+6.1%	-7.3%	+1.6%

Subscribe to Equity Analytics to compare BNTX with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.